Cargando…

The Antigenome: From Protein Subunit Vaccines to Antibody Treatments of Bacterial Infections?

New strategies are needed to master infectious diseases. The so-called “passive vaccination”, i.e., prevention and treatment with specific antibodies, has a proven record and potential in the management of infections and entered the medical arena more than 100 years ago. Progress in the identificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giefing, Carmen, Nagy, Eszter, von Gabain, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123057/ https://www.ncbi.nlm.nih.gov/pubmed/20047038 http://dx.doi.org/10.1007/978-1-4419-1132-2_9

Ejemplares similares

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
por: Giefing, Carmen, et al.
Publicado: (2008)

PP-085 Large scale protein expressions for antigenomics studies of respiratory viruses
por: Lu, G.L., et al.
Publicado: (2008)

How Follicular Dendritic Cells Shape the B-Cell Antigenome
por: Kranich, Jan, et al.
Publicado: (2016)

Serum Antigenome Profiling Reveals Diagnostic Models for Rheumatoid Arthritis
por: Han, Peng, et al.
Publicado: (2022)

A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme
por: Nehdi, Atef, et al.
Publicado: (2007)

Capped antigenomic RNA transcript facilitates rescue of a plant rhabdovirus
por: Qian, Shasha, et al.
Publicado: (2017)

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
por: Zhao, Lele, et al.
Publicado: (2022)

Antigenomic delta ribozyme variants with mutations in the catalytic core obtained by the in vitro selection method
por: Łęgiewicz, Michał, et al.
Publicado: (2006)

Mechanistic insight into the efficient packaging of antigenomic S RNA into Rift Valley fever virus particles
por: Tercero, Breanna, et al.
Publicado: (2023)

Unbiased in vitro selection reveals the unique character of the self-cleaving antigenomic HDV RNA sequence
por: Nehdi, Atef, et al.
Publicado: (2006)

Characterization of the Trans Watson-Crick GU Base Pair Located in the Catalytic Core of the Antigenomic HDV Ribozyme
por: Lévesque, Dominique, et al.
Publicado: (2012)

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
por: Angelova, Mihaela, et al.
Publicado: (2015)

The poly(A) site sequence in HDV RNA alters both extent and rate of self-cleavage of the antigenomic ribozyme
por: Brown, Abigail L., et al.
Publicado: (2008)

Strand-Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Measurement of Arenavirus Genomic and Antigenomic RNAs
por: Haist, Kelsey, et al.
Publicado: (2015)

RNase footprinting demonstrates antigenomic hepatitis delta virus ribozyme structural rearrangement as a result of self-cleavage reaction
por: Savochkina, Larissa, et al.
Publicado: (2008)

Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element
por: van Ooij, Mark J. M., et al.
Publicado: (2006)

How sex and age affect immune responses, susceptibility to infections, and response to vaccination
por: Giefing-Kröll, Carmen, et al.
Publicado: (2015)

Identification and validation of a novel microRNA-like molecule derived from a cytoplasmic RNA virus antigenome by bioinformatics and experimental approaches
por: Shi, Jiandong, et al.
Publicado: (2014)

The predicted stem-loop structure in the 3′-end of the human norovirus antigenomic sequence is required for its genomic RNA synthesis by its RdRp
por: Shimoike, Takashi, et al.
Publicado: (2021)

Interaction of HnRNP F with the guanine-rich segments in viral antigenomic RNA enhances porcine reproductive and respiratory syndrome virus-2 replication
por: Zhang, Aiguo, et al.
Publicado: (2022)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Advances in protein subunit vaccines against tuberculosis
por: Zhang, Ying, et al.
Publicado: (2023)

Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1()
por: Douglas, Alexander D., et al.
Publicado: (2010)

An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization
por: Lam, Joy-Yan, et al.
Publicado: (2023)

Peptide-Based Subunit Vaccine against Hookworm Infection
por: Skwarczynski, Mariusz, et al.
Publicado: (2012)

Therapeutic Uses of Bacterial Subunit Toxins
por: Lingwood, Clifford
Publicado: (2021)

Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
por: Guo, Shuxin, et al.
Publicado: (2023)

Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections
por: Xiao, Yuhong, et al.
Publicado: (2010)

A mathematical model of protein subunits COVID-19 vaccines
por: Gholami, Samaneh, et al.
Publicado: (2023)

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
por: Mandolesi, Marco, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
por: Wang-Lin, Shun Xin, et al.
Publicado: (2018)

Assembly landscape for the bacterial large ribosomal subunit
por: Sheng, Kai, et al.
Publicado: (2023)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Bacterial surface proteins and vaccines
por: Grandi, Guido
Publicado: (2010)

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
por: He, Yuxian, et al.
Publicado: (2004)

A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
por: Heidary, Mohsen, et al.
Publicado: (2022)

Case report: Myocarditis following COVID-19 protein subunit vaccination
por: Dong, Yi-ming, et al.
Publicado: (2022)

Uncommon Cause of Myocarditis After COVID-19 Protein Subunit Vaccine
por: Wang, Yi, et al.
Publicado: (2023)

A protein subunit vaccine elicits a balanced immune response that protects against Pseudomonas pulmonary infection
por: Howlader, Debaki R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vnkfpe99m05cu09mktf93sg0sm